Modifications and targeting of protein termini. Part A. /

Modifications and Targeting of Protein Termini, Volume 684 in the Methods in Enzymology series serial highlights new advances in the field, with this new volume presenting interesting chapters pn a variety of timely topics, including Optimizing purification and activity assays of N-terminal methyltr...

Full description

Bibliographic Details
Main Author: Arnesen, Thomas (Author)
Corporate Author: ScienceDirect (Online service)
Format: eBook
Language:English
Published: Kidlington, England : Academic Press, [2023]
Series:Issn Series.
Subjects:
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • Intro
  • Modifications and Targeting of Protein Termini: Part A
  • Copyright
  • Contents
  • Contributors
  • Preface: A nascent polypeptide emerges
  • Chapter One: Selective ribosome profiling as a tool to study interactions of translating ribosomes in mammalian cells
  • 1. Introduction
  • 2. Experimental design
  • 3. General considerations
  • 4. Cell growth, in vivo crosslinking, and cell lysis
  • 4.1. Equipment, materials, and buffer recipes
  • 4.2. Cell growth
  • 4.3. In vivo crosslinking (optional)
  • 4.4. Cell lysis
  • 5. Nuclease digestion and polysome profiling
  • 5.1. Equipment for polysome profiling
  • 5.2. Materials and buffer recipes
  • 5.3. Nuclease digest
  • 5.4. Polysome profiling
  • 6. Ribosome isolation for total translatome and selected translatome
  • 6.1. Ribosome isolation by sucrose cushion centrifugation
  • 6.1.1. Equipment
  • 6.1.2. Materials and buffer recipes
  • 6.1.3. Procedure
  • 6.2. Factor-bound RNC isolation from purified ribosomes
  • 6.2.1. Equipment
  • 6.2.2. Materials and buffer recipes
  • 6.2.3. Procedure
  • 6.3. Factor-bound RNC isolation from cell lysate
  • 6.3.1. Equipment
  • 6.3.2. Materials and buffer recipes
  • 6.3.3. Procedure
  • 7. Preparation of a ribosome footprint library
  • 7.1. Equipment
  • 7.2. Materials and buffer recipes
  • 7.3. Oligonucleotides
  • 7.4. General methods
  • 7.4.1. Precipitation of RNA
  • 7.4.2. Precipitation of DNA
  • 7.4.3. Polyacrylamide gel electrophoresis and gel extraction of nucleic acids
  • 7.5. Phenol-chloroform extraction
  • 7.6. Gel purification of ribosome-protected footprints
  • 7.7. Dephosphorylation
  • 7.8. Quantification of RNA and rRNA depletion
  • 7.9. Linker ligation at 3 end
  • 7.10. Reverse transcription of 3 ligated footprints to ssDNA
  • 7.11. Circularization of ssDNA
  • 7.12. PCR amplification
  • 7.13. Library quality control and deep sequencing.
  • 8. Data analysis
  • 9. Prospects and conclusion
  • Acknowledgments
  • References
  • Chapter Two: Deformylation of nascent peptide chains on the ribosome
  • 1. Introduction
  • 2. General methods
  • 3. PDF purification
  • 3.1. Purification of His6-tagged PDF
  • 3.1.1. Equipment
  • 3.1.2. Buffers and reagents
  • 3.1.3. Procedure
  • 3.1.4. Notes
  • 3.2. Preparation of fluorescent PDF(Bpy)
  • 3.2.1. Equipment
  • 3.2.2. Buffers and reagents
  • 3.2.3. Procedure
  • 3.2.4. Notes
  • 4. PDF substrates
  • 5. RNC deformylation
  • 5.1. Steady-state deformylation kinetics
  • 5.1.1. Equipment
  • 5.1.2. Buffer and reagents
  • 5.1.3. Procedure
  • 5.1.4. Analysis
  • 5.1.5. Notes
  • 5.2. Pre-steady-state kinetics
  • 5.2.1. Equipment
  • 5.2.2. Buffer and reagents
  • 5.2.3. Procedure
  • 5.2.4. Analysis
  • 5.2.5. Notes
  • 6. PDF-ribosome interactions
  • 6.1. PDF binding to the ribosome
  • 6.1.1. Equipment
  • 6.1.2. Buffer and reagents
  • 6.1.3. Procedure
  • 6.1.4. Analysis
  • 6.1.5. Notes
  • 6.2. Pre-steady-state kinetics
  • 6.2.1. Equipment
  • 6.2.2. Buffer and reagents
  • 6.2.3. Procedure
  • 6.2.4. Analysis
  • 6.2.5. Notes
  • 7. Conclusion
  • Acknowledgments
  • References
  • Chapter Three: Optimizing purification and activity assays of N-terminal methyltransferase complexes
  • 1. Introduction
  • 2. Design of single and dual expression constructs
  • 2.1. Equipment
  • 2.2. Reagents
  • 2.3. Procedure
  • 2.4. Notes
  • 3. Purification of recombinant protein
  • 3.1. Equipment
  • 3.2. Buffers, strains, and reagents
  • 3.3. Procedure
  • 3.4. Notes
  • 4. Western blot in vitro methyltransferase assays for full-length protein substrates
  • 4.1. Equipment
  • 4.2. Buffers, strains, and reagents
  • 4.3. Procedure
  • 4.4. Data analysis
  • 4.5. Notes
  • 5. Luminescent in vitro methyltransferase assays for peptide substrates
  • 5.1. Equipment
  • 5.2. Buffers and reagents.
  • 2.5.2. For storage at -20C
  • 3. Preparation of noncommercial N-myristoyl protein or CoA derivatives
  • 3.1. Myristoyl-CoA and any unusual CoA acyl derivatives
  • 3.2. Myristoylated protein substrates
  • 3.2.1. Fatty acid tagging of target proteins with NMT in vitro
  • 3.2.2. Myristoyl tagging in cell-free translation systems
  • 3.2.3. Bacteria-driven target labeling
  • 3.2.4. Quality controls
  • 4. Characterization of NMT-induced modifications on protein targets
  • 4.1. General considerations
  • 4.2. MALDI mass spectrometry
  • 4.2.1. Main outlines
  • 4.2.2. Notes
  • 4.3. The NMT/IpaJ pipeline
  • 4.4. Click chemistry-based protein imaging
  • 4.4.1. Overview
  • 4.4.2. In cellulo labeling procedures with acyl precursors
  • 4.4.3. In-gel imaging
  • 4.4.4. Immunoprecipitation
  • 4.4.5. Fluorescence imaging after immunoblotting
  • 5. Structural studies of NMT and its complexes with substrates and products
  • 5.1. Structural overview
  • 5.2. Crystallization and structure determination
  • 5.2.1. General crystallization conditions
  • 5.2.2. Obtaining crystals of NMT in complex with reactants or reaction intermediates
  • 5.2.3. Dataset collection, structure resolution, and refinement
  • 6. Conclusions and future prospects
  • Acknowledgments
  • Funding
  • References
  • Chapter Six: Kinetic and catalytic features of N-myristoyltransferases
  • 1. Introduction
  • 2. Materials, reagents, and buffers
  • 2.1. Equipment
  • 2.2. Enzymes
  • 2.3. Reagents
  • 2.3.1. Fatty acyl derivatives
  • 2.3.2. Peptides
  • 2.3.3. Notes
  • 2.4. Buffer components
  • 2.4.1. For storage at room temperature
  • 2.4.2. For storage at 4C
  • 2.4.3. For storage at -20C
  • 3. Kinetic analysis
  • 3.1. GNAT-specific kinetic properties and considerations
  • 3.2. Discontinuous assays
  • 3.2.1. Radioactive labeling
  • 3.2.2. HPLC assays
  • 3.3. Continuous assays.
  • 3.3.1. NMT activity coupling conditions
  • 3.3.2. Acylation kinetics
  • 3.3.3. Notes
  • 3.4. Catalytic efficiencies of various substrates: Ranges and meanings
  • 3.4.1. CoA donors
  • 3.4.2. Polypeptide acceptor donor
  • 4. Conclusions
  • Acknowledgments
  • Funding
  • References
  • Chapter Seven: Use of alkyne-tagged myristic acid to detect N-terminal myristoylation
  • 1. Introduction
  • 2. Synthesis of Alk-12probes
  • 2.1. 2-Tetradecyn-1-ol
  • 2.2. 13-Tetradecyn-1-ol
  • 2.3. 13-Tetradecynoic acid (Alk-12)
  • 3. Alk-12 and rhodamine labeling of targeted proteins in cells with click chemistry
  • 3.1. Equipment
  • 3.2. Materials, buffers, and reagents
  • 3.3. Procedure
  • 3.4. Notes
  • 4. Alk-12 and PEG-5000 labeling of targeted proteins
  • 4.1. Equipment
  • 4.2. Materials, buffers, and reagents
  • 4.3. Procedure
  • 4.4. Notes
  • 5. Global labeling of N-myristoylated proteins in whole cell lysate
  • 5.1. Equipment
  • 5.2. Materials, buffers, and reagents
  • 5.3. Procedure
  • 5.4. Notes
  • 6. Global profiling of N-myristoylated proteins using SILAC proteomics
  • 6.1. Equipment
  • 6.2. Materials, buffers, and reagents
  • 6.3. Procedure
  • 6.4. Notes
  • References
  • Chapter Eight: Peptide CoA conjugates for in situ proteomics profiling of acetyltransferase activities
  • 1. Introduction
  • 2. Peptide probe synthesis
  • 2.1. Before you begin
  • 2.2. Key resources table
  • 2.3. Materials and equipment
  • 2.4. Step-by-step method details
  • 2.4.1. Automated solid-phase peptide synthesis (SPPS)
  • 2.4.2. Peptide modifications
  • 2.4.3. Peptide cleavage and purification
  • 2.4.4. CoA conjugation
  • 2.4.5. Copper-catalyzed alkyne-azide cycloaddition (CuAAC)
  • 2.5. Expected outcomes
  • 2.6. Advantages
  • 2.7. Limitations
  • 2.8. Optimization and troubleshooting
  • 2.9. Safety considerations and standards
  • 2.10. Alternative methods/procedures.